U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07665294) titled 'Combination CurQD and Vedolizumab in Ulcerative Colitis' on June 18.
Brief Summary: The purpose of this research study is to test the efficacy and safety of the study intervention, CurQD or placebo (non-active pill), in combination with vedolizumab prescribed as standard of care for patients with ulcerative colitis (UC)..
Study Start Date: June 24
Study Type: INTERVENTIONAL
Condition:
Ulcerative Colitis
Intervention:
DRUG: CurQD
Capsule doses 235mg - 385mg curcumin/150mg-300mg QingDai
DRUG: Placebo
Matching capsules
DRUG: Vedolizumab
as prescribed by participant's provider as part of routine clinical care
Recruitment Sta...